Comparison of Three Field and Two Field Esophagectomy for Esophageal Cancer
Data Collection
Digestive System Diseases+6
+ Digestive System Neoplasms
+ Esophageal Diseases
Treatment Study
Summary
Study start date: January 1, 2005
Actual date on which the first participant was enrolled.Esophageal cancer is a common health issue worldwide, often associated with a poor outlook. Surgery is the main treatment, offering the best chance for a cure and long-term survival. However, results have been disappointing despite improvements in postoperative care and surgical techniques. This study aims to compare two surgical approaches: three-field and two-field esophagectomy, focusing on the efficacy of radical lymph node dissection in improving survival and quality of life. This research is important because there's currently no clear evidence on whether three-field lymphadenectomy, a more extensive procedure, significantly improves survival over two-field lymphadenectomy. The study will include patients with biopsy-proven esophageal cancer who are deemed operable and fit for major surgery. In this prospective randomized controlled trial, participants will undergo standard staging investigations, including CT scans and endoscopic ultrasounds. They will then be randomized into two groups, undergoing either three-field or two-field esophagectomy. The study will compare overall survival, disease-free survival, and postoperative complications between the two groups. It will also evaluate short and long-term quality of life after the procedures. All surgeries will be performed under general anesthesia, either by or under the direct supervision of experienced thoracic surgeons.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.700 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 70 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location